Steven Paget
Director, Head of Medicinal Chemistry @Aprinoia Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Director, Head of Medicinal Chemistry @Aprinoia Therapeutics
Cambridge, MA, US
EDUCATION
Cornell University
Bachelor of Arts (B.A.), Chemistry
The Ohio State University
Doctor of Philosophy (Ph.D.), Organic Chemistry
SKILLS
ABOUT STEVEN PAGET
Notable Accomplishments:• Novel STING agonist development candidate identified (Venenum Biodesign)• Discovered and developed RWJ-416457, an antimicrobial agent evaluated in First-in-Human /Phase I clinical trials (Janssen Pharmaceuticals)• Oncology development candidate identified for BMI1(PTC Therapeutics/Wellcome Trust)• Antiviral development candidate identified for Hepatitis C (PTC Therapeutics/Merck)
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.